Polymerase chain reaction (PCR) is a molecular biology technique used to amplify and detect specific DNA or RNA sequences. It is widely used in various applications, including genetic testing, diagnostic assays, and research.
The global Polymerase Chain Reaction (PCR) market was valued at US$ 6295.5 million in 2023 and is anticipated to reach US$ 8868.3 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The market for polymerase chain reaction (PCR) is driven by the demand for sensitive and specific molecular diagnostic solutions and the growing applications of PCR in infectious disease testing, genomics, and personalized medicine. The market's growth is also influenced by advancements in PCR technology, such as real-time PCR and digital PCR.
This report aims to provide a comprehensive presentation of the global market for Polymerase Chain Reaction (PCR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymerase Chain Reaction (PCR).
Report Scope
The Polymerase Chain Reaction (PCR) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polymerase Chain Reaction (PCR) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polymerase Chain Reaction (PCR) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Bio-Rad
QIAGEN
Roche
Thermo Fisher
BD
Abbott
Siemens
bioM茅rieux SA
Danaher
Agilent Technologies
Sansure Biotech
BGI Genomics
Wondfo Biotech
Hybribio Biotech
Lepu Medical
Amoy Diagnostics
Xilong Scientific
ZJ Bio-Tech Co., Ltd.
Tellgen Corporation
Bioperfectus Technologies
Kehua Bio-Engineering
EasyDiagnosis
Dian Diagnostics
Segment by Type
Instruments
Reagents & Consumables
Software & Services
Segment by Application
Clinical Diagnostics
Life Sciences
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polymerase Chain Reaction (PCR) companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Polymerase Chain Reaction (PCR) 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instruments
1.2.3 Reagents & Consumables
1.2.4 Software & Services
1.3 麻豆原创 by Application
1.3.1 Global Polymerase Chain Reaction (PCR) 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Diagnostics
1.3.3 Life Sciences
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Polymerase Chain Reaction (PCR) 麻豆原创 Perspective (2019-2030)
2.2 Polymerase Chain Reaction (PCR) Growth Trends by Region
2.2.1 Global Polymerase Chain Reaction (PCR) 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Polymerase Chain Reaction (PCR) Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Polymerase Chain Reaction (PCR) Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Polymerase Chain Reaction (PCR) 麻豆原创 Dynamics
2.3.1 Polymerase Chain Reaction (PCR) Industry Trends
2.3.2 Polymerase Chain Reaction (PCR) 麻豆原创 Drivers
2.3.3 Polymerase Chain Reaction (PCR) 麻豆原创 Challenges
2.3.4 Polymerase Chain Reaction (PCR) 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Polymerase Chain Reaction (PCR) Players by Revenue
3.1.1 Global Top Polymerase Chain Reaction (PCR) Players by Revenue (2019-2024)
3.1.2 Global Polymerase Chain Reaction (PCR) Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Polymerase Chain Reaction (PCR) 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Polymerase Chain Reaction (PCR) Revenue
3.4 Global Polymerase Chain Reaction (PCR) 麻豆原创 Concentration Ratio
3.4.1 Global Polymerase Chain Reaction (PCR) 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Polymerase Chain Reaction (PCR) Revenue in 2023
3.5 Polymerase Chain Reaction (PCR) Key Players Head office and Area Served
3.6 Key Players Polymerase Chain Reaction (PCR) Product Solution and Service
3.7 Date of Enter into Polymerase Chain Reaction (PCR) 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Polymerase Chain Reaction (PCR) Breakdown Data by Type
4.1 Global Polymerase Chain Reaction (PCR) Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Polymerase Chain Reaction (PCR) Forecasted 麻豆原创 Size by Type (2025-2030)
5 Polymerase Chain Reaction (PCR) Breakdown Data by Application
5.1 Global Polymerase Chain Reaction (PCR) Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Polymerase Chain Reaction (PCR) Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Polymerase Chain Reaction (PCR) 麻豆原创 Size (2019-2030)
6.2 North America Polymerase Chain Reaction (PCR) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Polymerase Chain Reaction (PCR) 麻豆原创 Size by Country (2019-2024)
6.4 North America Polymerase Chain Reaction (PCR) 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Polymerase Chain Reaction (PCR) 麻豆原创 Size (2019-2030)
7.2 Europe Polymerase Chain Reaction (PCR) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Polymerase Chain Reaction (PCR) 麻豆原创 Size by Country (2019-2024)
7.4 Europe Polymerase Chain Reaction (PCR) 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Polymerase Chain Reaction (PCR) 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Polymerase Chain Reaction (PCR) 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Polymerase Chain Reaction (PCR) 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Polymerase Chain Reaction (PCR) 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Polymerase Chain Reaction (PCR) 麻豆原创 Size (2019-2030)
9.2 Latin America Polymerase Chain Reaction (PCR) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Polymerase Chain Reaction (PCR) 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Polymerase Chain Reaction (PCR) 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Polymerase Chain Reaction (PCR) 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Polymerase Chain Reaction (PCR) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Polymerase Chain Reaction (PCR) 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Polymerase Chain Reaction (PCR) 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Detail
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad Polymerase Chain Reaction (PCR) Introduction
11.1.4 Bio-Rad Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.1.5 Bio-Rad Recent Development
11.2 QIAGEN
11.2.1 QIAGEN Company Detail
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Polymerase Chain Reaction (PCR) Introduction
11.2.4 QIAGEN Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.2.5 QIAGEN Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Polymerase Chain Reaction (PCR) Introduction
11.3.4 Roche Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Thermo Fisher
11.4.1 Thermo Fisher Company Detail
11.4.2 Thermo Fisher Business Overview
11.4.3 Thermo Fisher Polymerase Chain Reaction (PCR) Introduction
11.4.4 Thermo Fisher Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.4.5 Thermo Fisher Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD Polymerase Chain Reaction (PCR) Introduction
11.5.4 BD Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.5.5 BD Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Polymerase Chain Reaction (PCR) Introduction
11.6.4 Abbott Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 Siemens
11.7.1 Siemens Company Detail
11.7.2 Siemens Business Overview
11.7.3 Siemens Polymerase Chain Reaction (PCR) Introduction
11.7.4 Siemens Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.7.5 Siemens Recent Development
11.8 bioM茅rieux SA
11.8.1 bioM茅rieux SA Company Detail
11.8.2 bioM茅rieux SA Business Overview
11.8.3 bioM茅rieux SA Polymerase Chain Reaction (PCR) Introduction
11.8.4 bioM茅rieux SA Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.8.5 bioM茅rieux SA Recent Development
11.9 Danaher
11.9.1 Danaher Company Detail
11.9.2 Danaher Business Overview
11.9.3 Danaher Polymerase Chain Reaction (PCR) Introduction
11.9.4 Danaher Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.9.5 Danaher Recent Development
11.10 Agilent Technologies
11.10.1 Agilent Technologies Company Detail
11.10.2 Agilent Technologies Business Overview
11.10.3 Agilent Technologies Polymerase Chain Reaction (PCR) Introduction
11.10.4 Agilent Technologies Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.10.5 Agilent Technologies Recent Development
11.11 Sansure Biotech
11.11.1 Sansure Biotech Company Detail
11.11.2 Sansure Biotech Business Overview
11.11.3 Sansure Biotech Polymerase Chain Reaction (PCR) Introduction
11.11.4 Sansure Biotech Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.11.5 Sansure Biotech Recent Development
11.12 BGI Genomics
11.12.1 BGI Genomics Company Detail
11.12.2 BGI Genomics Business Overview
11.12.3 BGI Genomics Polymerase Chain Reaction (PCR) Introduction
11.12.4 BGI Genomics Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.12.5 BGI Genomics Recent Development
11.13 Wondfo Biotech
11.13.1 Wondfo Biotech Company Detail
11.13.2 Wondfo Biotech Business Overview
11.13.3 Wondfo Biotech Polymerase Chain Reaction (PCR) Introduction
11.13.4 Wondfo Biotech Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.13.5 Wondfo Biotech Recent Development
11.14 Hybribio Biotech
11.14.1 Hybribio Biotech Company Detail
11.14.2 Hybribio Biotech Business Overview
11.14.3 Hybribio Biotech Polymerase Chain Reaction (PCR) Introduction
11.14.4 Hybribio Biotech Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.14.5 Hybribio Biotech Recent Development
11.15 Lepu Medical
11.15.1 Lepu Medical Company Detail
11.15.2 Lepu Medical Business Overview
11.15.3 Lepu Medical Polymerase Chain Reaction (PCR) Introduction
11.15.4 Lepu Medical Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.15.5 Lepu Medical Recent Development
11.16 Amoy Diagnostics
11.16.1 Amoy Diagnostics Company Detail
11.16.2 Amoy Diagnostics Business Overview
11.16.3 Amoy Diagnostics Polymerase Chain Reaction (PCR) Introduction
11.16.4 Amoy Diagnostics Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.16.5 Amoy Diagnostics Recent Development
11.17 Xilong Scientific
11.17.1 Xilong Scientific Company Detail
11.17.2 Xilong Scientific Business Overview
11.17.3 Xilong Scientific Polymerase Chain Reaction (PCR) Introduction
11.17.4 Xilong Scientific Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.17.5 Xilong Scientific Recent Development
11.18 ZJ Bio-Tech Co., Ltd.
11.18.1 ZJ Bio-Tech Co., Ltd. Company Detail
11.18.2 ZJ Bio-Tech Co., Ltd. Business Overview
11.18.3 ZJ Bio-Tech Co., Ltd. Polymerase Chain Reaction (PCR) Introduction
11.18.4 ZJ Bio-Tech Co., Ltd. Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.18.5 ZJ Bio-Tech Co., Ltd. Recent Development
11.19 Tellgen Corporation
11.19.1 Tellgen Corporation Company Detail
11.19.2 Tellgen Corporation Business Overview
11.19.3 Tellgen Corporation Polymerase Chain Reaction (PCR) Introduction
11.19.4 Tellgen Corporation Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.19.5 Tellgen Corporation Recent Development
11.20 Bioperfectus Technologies
11.20.1 Bioperfectus Technologies Company Detail
11.20.2 Bioperfectus Technologies Business Overview
11.20.3 Bioperfectus Technologies Polymerase Chain Reaction (PCR) Introduction
11.20.4 Bioperfectus Technologies Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.20.5 Bioperfectus Technologies Recent Development
11.21 Kehua Bio-Engineering
11.21.1 Kehua Bio-Engineering Company Detail
11.21.2 Kehua Bio-Engineering Business Overview
11.21.3 Kehua Bio-Engineering Polymerase Chain Reaction (PCR) Introduction
11.21.4 Kehua Bio-Engineering Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.21.5 Kehua Bio-Engineering Recent Development
11.22 EasyDiagnosis
11.22.1 EasyDiagnosis Company Detail
11.22.2 EasyDiagnosis Business Overview
11.22.3 EasyDiagnosis Polymerase Chain Reaction (PCR) Introduction
11.22.4 EasyDiagnosis Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.22.5 EasyDiagnosis Recent Development
11.23 Dian Diagnostics
11.23.1 Dian Diagnostics Company Detail
11.23.2 Dian Diagnostics Business Overview
11.23.3 Dian Diagnostics Polymerase Chain Reaction (PCR) Introduction
11.23.4 Dian Diagnostics Revenue in Polymerase Chain Reaction (PCR) Business (2019-2024)
11.23.5 Dian Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Bio-Rad
QIAGEN
Roche
Thermo Fisher
BD
Abbott
Siemens
bioM茅rieux SA
Danaher
Agilent Technologies
Sansure Biotech
BGI Genomics
Wondfo Biotech
Hybribio Biotech
Lepu Medical
Amoy Diagnostics
Xilong Scientific
ZJ Bio-Tech Co., Ltd.
Tellgen Corporation
Bioperfectus Technologies
Kehua Bio-Engineering
EasyDiagnosis
Dian Diagnostics
听
听
*If Applicable.